Used in pharmaceutical research as a potential antipsychotic agent due to its interaction with dopamine and serotonin receptors. Shows activity in modulating central nervous system pathways, making it a candidate for the development of drugs targeting schizophrenia and related psychiatric disorders. Also investigated for its anxiolytic and antidepressant-like effects in preclinical models. Its structure supports blood-brain barrier penetration, enhancing its potential as a central nervous system therapeutic agent.